Karkinos and IIT-B collaborate to fight cancer

Karkinos Healthcare and the Indian Institute of Technology (IIT) Bombay collaborate to bring together the expertise of more than 100 medical professionals and academics in order to enhance cancer treatment. Through this partnership, industry and academic expertise will be combined to develop next-generation omics technologies to fight cancer.

A project has been started on brain tumours, which are still among the deadliest cancers, by teams from Karkinos and IIT Bombay. The team intends to extend its research to other cancers that are often diagnosed in India. Proteins or genes alone can only provide a limited amount of information. As a result, new efforts have been made by the researchers to expand proteogenomics investigations in cancers by combining mass spectrometry-based proteomics data with genomics.

“The advancements in genomics and proteomics in recent years has given a remarkable boost to our understanding about the disease pathology. Proteogenomics are adding new capabilities of providing novel insights at an unprecedented scale, which was not possible earlier,” a statement said.

Prof. Sanjeeva Srivastava of IIT Bombay commented on the collaboration, saying, “At IIT Bombay, we have setup large infrastructure of proteomics-based technologies using mass spectrometry and protein microarrays to identify protein-based biomarkers.” To speed up biological and biomedical research, Karkinos has established cutting-edge genomics technology and data analysis.

“In a short time, we have enabled the latest next generation sequencing platforms and multi-omics data analysis workflow to sequence alterations in cancer genomes. We have streamlined the whole genome sequencing process which will offer rapid, accurate variant analysis,” said Dr Prashant Kumar,Chief Scientific Officer, Karkinos Healthcare. ArdorComm Media Group